Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 2/2014

01.02.2014 | 2013 SSAT Plenary Presentation

Development and Characterization of a Surgical Mouse Model of Reflux Esophagitis and Barrett's Esophagus

verfasst von: Thai H. Pham, Robert M. Genta, Stuart Jon Spechler, Rhonda F. Souza, David H. Wang

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Ideally, an animal model of Barrett's esophagus should recapitulate the human disease histologically and immunohistochemically, and be readily susceptible to genetic manipulation. We have developed such a model using a strain of mice commonly used for transgenic and knockout manipulations. We induced reflux by esophagojejunostomy (EJ) in 20 C57Bl/6 mice. At defined time points, sections of the esophagus were stained with H&E and Alcian blue, and immunohistochemical staining was performed for Sox9 (a transcription factor in Barrett's metaplasia), cytokeratin (CK) 8/18 (a columnar marker) and CK14 (a squamous marker). Procedural mortality was 40% for the first ten animals, 20% for the next 10. Reflux esophagitis developed by 13 weeks, and intestinal metaplasia with goblet cells developed by 34 weeks. The metaplasia expressed CK8/18, but not CK14, and exhibited nuclear immunostaining for Sox9. Nuclear Sox9 was also seen in scattered basal cells of squamous epithelium close to the EJ anastomosis. EJ can be performed successfully in C57Bl/6 mice, resulting in reflux esophagitis and intestinal metaplasia that exhibits phenotypic and molecular features of human Barrett's metaplasia. This surgical model in a mouse strain that is easy to manipulate genetically should be a valuable tool for studying the pathogenesis of Barrett's esophagus.
Literatur
1.
Zurück zum Zitat Cook MB, Chow WH, Devesa SS. Oesophageal cancer incidence in the United States by race, sex, and histologic types, 1977–2005. Br J Cancer 2009; 101(5):855–9.PubMedCentralPubMedCrossRef Cook MB, Chow WH, Devesa SS. Oesophageal cancer incidence in the United States by race, sex, and histologic types, 19772005. Br J Cancer 2009; 101(5):855–9.PubMedCentralPubMedCrossRef
2.
Zurück zum Zitat Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ. American Gastroenterological Association. American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology 2011; 140(3): e18-52.PubMedCentralPubMedCrossRef Spechler SJ, Sharma P, Souza RF, Inadomi JM, Shaheen NJ. American Gastroenterological Association. American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology 2011; 140(3): e18-52.PubMedCentralPubMedCrossRef
3.
Zurück zum Zitat Levrat M, Lambert R, Kirshbaum G. Esophagitis produced by reflux of duodenal conents in rats. Am J Dig Dis 1962.;7: 564–73.PubMedCrossRef Levrat M, Lambert R, Kirshbaum G. Esophagitis produced by reflux of duodenal conents in rats. Am J Dig Dis 1962.;7: 564–73.PubMedCrossRef
4.
Zurück zum Zitat Goldstein SR, Yang GY, Curtis SK, Reuhl KR, Liu BC, Mirvish SS, Newmark HL, Yang CS. Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis 1997;18(11): 2265–70.PubMedCrossRef Goldstein SR, Yang GY, Curtis SK, Reuhl KR, Liu BC, Mirvish SS, Newmark HL, Yang CS. Development of esophageal metaplasia and adenocarcinoma in a rat surgical model without the use of a carcinogen. Carcinogenesis 1997;18(11): 2265–70.PubMedCrossRef
5.
Zurück zum Zitat Fein M, Peters JH, Chandrasoma P, Ireland AP, Oberg S, Ritter MP, Bremner CG, Hagen JA, DeMeester TR. Duodenoesophageal reflux induces esophageal adenocarcinoma without exogenous carcinogen. J Gastrointest Surg 1998; 2(3): 260–9.PubMedCrossRef Fein M, Peters JH, Chandrasoma P, Ireland AP, Oberg S, Ritter MP, Bremner CG, Hagen JA, DeMeester TR. Duodenoesophageal reflux induces esophageal adenocarcinoma without exogenous carcinogen. J Gastrointest Surg 1998; 2(3): 260–9.PubMedCrossRef
6.
Zurück zum Zitat Rizvi S, Demars CJ, Comba A, Gainullin VG, Rizvi Z, Almada LL, Wang K, Lomberk G, Fernandez-Zapico ME, Buttar NS. Combinatorial chemoprevention reveals a novel smoothened-independent role of GLI1 in esophageal carcinogenesis. Cancer Res 2010; 70(17): 6787–96.PubMedCentralPubMedCrossRef Rizvi S, Demars CJ, Comba A, Gainullin VG, Rizvi Z, Almada LL, Wang K, Lomberk G, Fernandez-Zapico ME, Buttar NS. Combinatorial chemoprevention reveals a novel smoothened-independent role of GLI1 in esophageal carcinogenesis. Cancer Res 2010; 70(17): 6787–96.PubMedCentralPubMedCrossRef
7.
8.
Zurück zum Zitat Fein M, Peters JH, Baril N, McGarvey M, Chandrasoma P, Shibata D, Laird PW, Skinner KA. Loss of function of Trp53, but not Apc, leads to the development of esophageal adenocarcinoma in mice with jejunoesophageal reflux. J Surg Res 1999;83(1): 48–56.PubMedCrossRef Fein M, Peters JH, Baril N, McGarvey M, Chandrasoma P, Shibata D, Laird PW, Skinner KA. Loss of function of Trp53, but not Apc, leads to the development of esophageal adenocarcinoma in mice with jejunoesophageal reflux. J Surg Res 1999;83(1): 48–56.PubMedCrossRef
9.
Zurück zum Zitat Duncan MD, Tihan T, Donovan DM, Phung QH, Rowley DL, Harmon JW, Gearhart PJ, Duncan KL. Esophagogastric adenocarcinoma in E1A/E1B transgenic model involves p53 disruption. J Gastrointest Surg 2000;4(3): 290–7.PubMedCrossRef Duncan MD, Tihan T, Donovan DM, Phung QH, Rowley DL, Harmon JW, Gearhart PJ, Duncan KL. Esophagogastric adenocarcinoma in E1A/E1B transgenic model involves p53 disruption. J Gastrointest Surg 2000;4(3): 290–7.PubMedCrossRef
10.
Zurück zum Zitat Raggi M, Langer R, Feith M, Friess H, Schauer M, Theisen J. Successful evaluation of a new animal model using mice for esophageal adenocarcinoma. Langenbecks Arch Surg 2010; 395(4): 347–50.PubMedCrossRef Raggi M, Langer R, Feith M, Friess H, Schauer M, Theisen J. Successful evaluation of a new animal model using mice for esophageal adenocarcinoma. Langenbecks Arch Surg 2010; 395(4): 347–50.PubMedCrossRef
11.
Zurück zum Zitat Xu X, LoCicero J 3rd, Macri E, Loda M, Ellis FH Jr.. Barrett's esophagus and associated adenocarcinoma in a mouse surgical model. J Surg Res 2000;88(2): 120–4.PubMedCrossRef Xu X, LoCicero J 3rd, Macri E, Loda M, Ellis FH Jr.. Barrett's esophagus and associated adenocarcinoma in a mouse surgical model. J Surg Res 2000;88(2): 120–4.PubMedCrossRef
12.
Zurück zum Zitat Battey J, Jordan E, Cox D, Dove W. An action plan for mouse genomics. Nature Genetics 1999; 21(1): 73–5.PubMedCrossRef Battey J, Jordan E, Cox D, Dove W. An action plan for mouse genomics. Nature Genetics 1999; 21(1): 73–5.PubMedCrossRef
13.
Zurück zum Zitat Wang DH, Clemons NJ, Miyashita T, Dupuy AJ, Zhang W, Szczepny A, Corcoran-Schwartz IM, Wilburn DL, Montgomery EA, Wang JS, Jenkins NA, Copeland NA, Harmon JW, Watkins DN. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia. Gastroenterology 2010; 138(5): 1810–22.PubMedCentralPubMedCrossRef Wang DH, Clemons NJ, Miyashita T, Dupuy AJ, Zhang W, Szczepny A, Corcoran-Schwartz IM, Wilburn DL, Montgomery EA, Wang JS, Jenkins NA, Copeland NA, Harmon JW, Watkins DN. Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia. Gastroenterology 2010; 138(5): 1810–22.PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Formeister EJ, Sionas AL, Lorance DK, Barkley CL, Lee GH, Magness ST. Distinct SOX9 levels differentially mark stem/progenitor populations and enteroendocrine cells of the small intestine epithelium. Physiol Gastrointest Liver Physiol 2009; 296(5): G1108-18.CrossRef Formeister EJ, Sionas AL, Lorance DK, Barkley CL, Lee GH, Magness ST. Distinct SOX9 levels differentially mark stem/progenitor populations and enteroendocrine cells of the small intestine epithelium. Physiol Gastrointest Liver Physiol 2009; 296(5): G1108-18.CrossRef
15.
Zurück zum Zitat Clemons NJ, Wang DH, Croagh D, Tikoo A, Fennell CM, Murone C, Scott AM, Watkins DN, Phillips WA. Sox9 drives columnar differentiation of esophageal squamous epithelium: a possible role in the pathogenesis of Barrett's esophagus. Am J Physiol Gastrointest Liver Physiol 2012; 303(12): G1334-46.CrossRef Clemons NJ, Wang DH, Croagh D, Tikoo A, Fennell CM, Murone C, Scott AM, Watkins DN, Phillips WA. Sox9 drives columnar differentiation of esophageal squamous epithelium: a possible role in the pathogenesis of Barrett's esophagus. Am J Physiol Gastrointest Liver Physiol 2012; 303(12): G1334-46.CrossRef
16.
Zurück zum Zitat Burke ZD, Tosh D. Barrett's metaplasia as a paradigm for understanding the development of cancer. Curr Opin Genet Dev 2012; 22(5): 494–9.PubMedCrossRef Burke ZD, Tosh D. Barrett's metaplasia as a paradigm for understanding the development of cancer. Curr Opin Genet Dev 2012; 22(5): 494–9.PubMedCrossRef
17.
Zurück zum Zitat Quante M, Bhagat G, Abrams JA, Marache F, Good P, Lee MD, Lee Y, Friedman R, Asfaha S, Dubeykovskaya Z, Mahmood U, Figueiredo JL, Kitajewski J, Shawber C, Lightdale CJ, Rustgi AK, Wang TC. Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell 2012; 21(1): 36–51.PubMedCentralPubMedCrossRef Quante M, Bhagat G, Abrams JA, Marache F, Good P, Lee MD, Lee Y, Friedman R, Asfaha S, Dubeykovskaya Z, Mahmood U, Figueiredo JL, Kitajewski J, Shawber C, Lightdale CJ, Rustgi AK, Wang TC. Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia. Cancer Cell 2012; 21(1): 36–51.PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Wang X, Ouyang H, Yamamoto Y, Kumar PA, Wei TS, Dagher R, Vincent M, Lu X, Bellizzi AM, Ho KY, Crum CP, Xian W, McKeon F. Residual embryonic cells as precursors of a Barrett's-like metaplasia. Cell 2011; 145(7): 1023–35.PubMedCentralPubMedCrossRef Wang X, Ouyang H, Yamamoto Y, Kumar PA, Wei TS, Dagher R, Vincent M, Lu X, Bellizzi AM, Ho KY, Crum CP, Xian W, McKeon F. Residual embryonic cells as precursors of a Barrett's-like metaplasia. Cell 2011; 145(7): 1023–35.PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Glickman JN, Chen YY, Wang HH, Antonioli DA, Odze RD. Phenotypic characteristics of a distinctive multilayer epithelium suggests that it is a precursor in the development of Barrett's esophagus. Am J Surg Pathol 2001; 25(5): 569–78.PubMedCrossRef Glickman JN, Chen YY, Wang HH, Antonioli DA, Odze RD. Phenotypic characteristics of a distinctive multilayer epithelium suggests that it is a precursor in the development of Barrett's esophagus. Am J Surg Pathol 2001; 25(5): 569–78.PubMedCrossRef
Metadaten
Titel
Development and Characterization of a Surgical Mouse Model of Reflux Esophagitis and Barrett's Esophagus
verfasst von
Thai H. Pham
Robert M. Genta
Stuart Jon Spechler
Rhonda F. Souza
David H. Wang
Publikationsdatum
01.02.2014
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 2/2014
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-013-2386-z

Weitere Artikel der Ausgabe 2/2014

Journal of Gastrointestinal Surgery 2/2014 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.